Massimo Pieri
Impact in
Papers in
-
- COVID-19 Clinical Research Studies 23
- SARS-CoV-2 and COVID-19 Research 23
- SARS-CoV-2 detection and testing 16
- Neurology 31
- Parkinson's Disease Mechanisms and Treatments 18
- Amyotrophic Lateral Sclerosis Research 15
- Co-authors
- Cristina Zona (27 shared papers)Sergio Bernardini (77 shared papers)Irene Carunchio (11 shared papers)Federica Albo (4 shared papers)Nicola Biagio Mercuri (12 shared papers)Marco Ciotti (16 shared papers)Alessandro Marroni (19 shared papers)Marzia Nuccetelli (17 shared papers)
- Journals
- International Journal of Molecular Sciences (7 papers)International Immunopharmacology (6 papers)Neuropharmacology (4 papers)Journal of Medical Virology (3 papers)Journal of Neuroimmunology (3 papers)
- Partner nations
- ItalyUnited StatesQatar
In The Last Decade
Massimo Pieri
139 papers receiving 2.6k citations
Massimo Pieri's Hit Papers
Peers
Comparison fields: 5 of 146
- Neurology 710
- Genetics 285
- Cellular and Molecular Neuroscience 478
- Infectious Diseases 464
- Neurology 140
Countries citing papers authored by Massimo Pieri
This map shows the geographic impact of Massimo Pieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Pieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Pieri more than expected).
Fields of papers citing papers by Massimo Pieri
This network shows the impact of papers produced by Massimo Pieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Pieri. The network helps show where Massimo Pieri may publish in the future.
Co-authors
The 25 scholars most cited alongside Massimo Pieri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 152 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anti-Inflammatory and Active Biological Properties of the Plant-Derived Bioactive Compounds Luteolin and Luteolin 7-Glucoside Hit paper breakdown → | 2022 | 149 |
| 2 | 2008 | 115 | |
| 3 | 2003 | 112 | |
| 4 | 2007 | 108 | |
| 5 | 2021 | 89 | |
| 6 | 2015 | 84 | |
| 7 | 2021 | 76 | |
| 8 | 2007 | 70 | |
| 9 | 2013 | 65 | |
| 10 | 2021 | 64 | |
| 11 | 2020 | 60 | |
| 12 | 2009 | 59 | |
| 13 | 2004 | 53 | |
| 14 | 2021 | 48 | |
| 15 | 2017 | 46 | |
| 16 | 2006 | 46 | |
| 17 | 2007 | 46 | |
| 18 | 2009 | 42 | |
| 19 | 2015 | 42 | |
| 20 | 2007 | 41 |
About Massimo Pieri
Massimo Pieri is a scholar working on Infectious Diseases, Neurology, Molecular Biology, Pulmonary and Respiratory Medicine and Physiology, having authored 152 papers that have together received 2.7k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (23 papers), SARS-CoV-2 and COVID-19 Research (23 papers), Cardiovascular and Diving-Related Complications (19 papers), Parkinson's Disease Mechanisms and Treatments (18 papers), SARS-CoV-2 detection and testing (16 papers), Amyotrophic Lateral Sclerosis Research (15 papers), High Altitude and Hypoxia (13 papers) and Neuroscience and Neuropharmacology Research (12 papers). The work is most often cited by research in Neurology (710 citations), Genetics (285 citations), Cellular and Molecular Neuroscience (478 citations), Infectious Diseases (464 citations) and Neurology (140 citations). Massimo Pieri has collaborated with scholars based in Italy, United States and Qatar. Frequent co-authors include Cristina Zona, Sergio Bernardini, Irene Carunchio, Federica Albo, Nicola Biagio Mercuri, Marco Ciotti, Alessandro Marroni, Marzia Nuccetelli, Danilo Cialoni and Marilena Minieri. Their work appears in journals such as International Journal of Molecular Sciences, International Immunopharmacology, Neuropharmacology, Journal of Medical Virology and Journal of Neuroimmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.